Laserfiche WebLink
FINAL AGREEMENT 3.25.22 <br /> 4. Research on novel harm reduction and prevention efforts such as the <br /> provision of fentanyl test strips. <br /> 5. Research on innovative supply-side enforcement efforts such as improved <br /> detection of mail-based delivery of synthetic opioids. <br /> 6. Expanded research on swift/certain/fair models to reduce and deter opioid <br /> misuse within criminal justice populations that build upon promising <br /> approaches used to address other substances (e.g.,Hawaii HOPE and <br /> Dakota 24/7). <br /> 7. Epidemiological surveillance of OUD-related behaviors in critical <br /> populations,including individuals entering the criminal justice system, <br /> including,but not limited to approaches modeled on the Arrestee Drug <br /> Abuse Monitoring("ADAM") system. <br /> 8. Qualitative and quantitative research regarding public health risks and <br /> harm reduction opportunities within illicit drug markets,including surveys <br /> of market participants who sell or distribute illicit opioids. <br /> 9. Geospatial analysis of access barriers to MAT and their association with <br /> treatment engagement and treatment outcomes. <br /> E-15 <br />